EMPAGLIFLOZINA 25 MG COM REV CT BL AL AL X 90

Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil

  • Registration number 1351700960200
  • GGREM 543826080109607
  • Barcode 7898687739374

What the source publishes

Holder
ALTHAIA S.A. INDUSTRIA FARMACEUTICA
Active ingredients
EMPAGLIFLOZINA
Package
25 MG COM REV CT BL AL AL X 90
Supply regime
Tarja Vermelha
Product type
Genérico
Therapeutic class
A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
Prescription
Prescription or restricted

Names this record is found by

Complete source data
br:cmed:presentations:543826080109607
{
  "name": "EMPAGLIFLOZINA 25 MG COM REV CT BL AL AL X 90",
  "holder": "ALTHAIA S.A. INDUSTRIA FARMACEUTICA",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7898687739374"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "543826080109607",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "48.344.725/0007-19",
  "priceRegime": "Regulado",
  "productName": "EMPAGLIFLOZINA",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "25 MG COM REV CT BL AL AL X 90",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "387.33",
    "icms-12": "440.15",
    "icms-17": "466.66",
    "icms-18": "472.35",
    "icms-19": "478.19",
    "icms-20": "484.16",
    "icms-21": "490.29",
    "icms-22": "496.58",
    "icms-23": "503.03",
    "icms-17.5": "469.49",
    "icms-19.5": "481.16",
    "icms-20.5": "487.21",
    "icms-22.5": "499.78",
    "icms-12-alc": "392.99",
    "icms-17-alc": "416.66",
    "icms-18-alc": "421.74",
    "icms-19-alc": "426.95",
    "icms-20-alc": "432.29",
    "icms-21-alc": "437.76",
    "icms-22-alc": "443.37",
    "icms-23-alc": "449.13",
    "withoutTaxes": "345.83",
    "icms-17.5-alc": "419.19",
    "icms-19.5-alc": "429.60",
    "icms-20.5-alc": "435.01",
    "icms-22.5-alc": "446.23"
  },
  "pisCofinsList": "Negativa",
  "substanceText": "EMPAGLIFLOZINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "519.59",
    "icms-12": "590.45",
    "icms-17": "626.01",
    "icms-18": "633.64",
    "icms-19": "641.47",
    "icms-20": "649.48",
    "icms-21": "657.71",
    "icms-22": "666.14",
    "icms-23": "674.80",
    "icms-17.5": "629.80",
    "icms-19.5": "645.46",
    "icms-20.5": "653.57",
    "icms-22.5": "670.44",
    "icms-12-alc": "543.29",
    "icms-17-alc": "576.01",
    "icms-18-alc": "583.03",
    "icms-19-alc": "590.23",
    "icms-20-alc": "597.62",
    "icms-21-alc": "605.18",
    "icms-22-alc": "612.93",
    "icms-23-alc": "620.90",
    "withoutTaxes": "478.09",
    "icms-17.5-alc": "579.51",
    "icms-19.5-alc": "593.90",
    "icms-20.5-alc": "601.38",
    "icms-22.5-alc": "616.89"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "EMPAGLIFLOZINA"
  ],
  "therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
  "commercialisation": {
    "year": 2025,
    "marketed": false
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1351700960200",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "A10P1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:543826080109607"